Autoimmune Diseases  >>  dalfampridine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dalfampridine / Generic mfg.
NCT01356940: A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis

Completed
4
43
US
dalfampridine ER, Ampyra serial number 77948545, placebo, Sugar Pill
Brown, Theodore R., M.D., MPH, Acorda Therapeutics
Multiple Sclerosis
04/13
04/13
FAME, NCT01656148 / 2011-006151-10: - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra

Completed
4
108
Europe
Fampridine-SR, Fampyra (Ampyra in the US).
University of Southern Denmark, Region of Southern Denmark, Biogen
Multiple Sclerosis
05/14
05/14
RETRAP, NCT02143167 / 2011-002959-34: Resistance Training and Amino Pyridine in Multiple Sclerosis

Completed
4
40
Europe
SR-fampridine, Fampyra, Placebo
University of Southern Denmark, Region of Southern Denmark, Biogen
Multiple Sclerosis
01/15
01/15
NCT02146534: Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients

Completed
4
44
Canada
extended release fampridine, Fampyra, Placebo
Clinique Neuro-Outaouais, CogState Ltd.
Multiple Sclerosis
01/16
01/16

Download Options